| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0067 | 0.9 |